Authors:
VALERO V
JONES SE
VONHOFF DD
BOOSER DJ
MENNEL RG
RAVDIN PM
HOLMES FA
RAHMAN Z
SCHOTTSTAEDT MW
ERBAN JK
ESPARZAGUERRA L
EARHART RH
HORTOBAGYI GN
BURRIS HA
Citation: V. Valero et al., A PHASE-II STUDY OF DOCETAXEL IN PATIENTS WITH PACLITAXEL-RESISTANT METASTATIC BREAST-CANCER, Journal of clinical oncology, 16(10), 1998, pp. 3362-3368
Authors:
FOSTER BJ
LORUSSO PM
POPLIN E
ZALUPSKI M
VALDIVIESO M
WOZNIAK A
FLAHERTY L
KASUNIC DA
EARHART RH
BAKER LH
Citation: Bj. Foster et al., PHASE-I TRIAL OF ADOZELESIN USING THE TREATMENT SCHEDULE OF DAILY X 5EVERY 3 WEEKS, Investigational new drugs, 13(4), 1995, pp. 321-326
Authors:
FLEMING GF
RATAIN MJ
OBRIEN SM
SCHILSKY RL
HOFFMAN PC
RICHARDS JM
VOGELZANG NJ
KASUNIC DA
EARHART RH
Citation: Gf. Fleming et al., PHASE-I STUDY OF ADOZELESIN ADMINISTERED BY 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION, Journal of the National Cancer Institute, 86(5), 1994, pp. 368-372
Citation: Dr. Welch et al., EVIDENCE FOR PARACRINE REGULATION OF EXPERIMENTAL METASTASIS IN 13762NF RAT MAMMARY ADENOCARCINOMA CELL CLONES, Anticancer research, 14(5A), 1994, pp. 1743-1751
Authors:
WEISS GR
BROWN TD
KUHN JG
VONHOFF DD
EARHART RH
ADAMS WJ
BREWER JE
HOSLEY JD
KASUNIC DA
Citation: Gr. Weiss et al., A PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF THE ORAL AND THE ORALINTRAVENOUS ADMINISTRATION OF MENOGARIL, Investigational new drugs, 11(1), 1993, pp. 17-27